CompletedNCT01559454
Buprenorphine or Methadone for Chronic Back Pain With Opioid Use
About this title
Read the official source — NCT01559454Medication studyAges 18–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- AmherstSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateFebruary 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 19
- Sponsor
- State University of New York at Buffalo
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01559454
- Official title
Show the full official title
A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Treatment in Opioid Dependent Chronic Back Pain Patients
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Amherst
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is State University of New York at Buffalo, a university.
Did this study involve medication?
Yes. The study involved medication, including Methadone and Buprenorphine/naloxone.
Who was this study for?
Listed age limits: 18 years to 65 years.
